Status:

UNKNOWN

Role of Intestinal Protozoa and Helminths in the Course of Ulcerative Colitis

Lead Sponsor:

Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan

Conditions:

Ulcerative Colitis

Ulcerative Colitis Exacerbation

Eligibility:

All Genders

18-90 years

Phase:

PHASE1

PHASE2

Brief Summary

Ulcerative colitis (UC) is a chronic inflammatory disorder of the gastrointestinal tract of unknown etiology. UC is characterized by recurring episodes of inflammation limited to mucosal and submucosa...

Detailed Description

The prospective cohort and randomized, double-blind, placebo controlled study will be conducted on the basis of Research Institute of Epidemiology, Microbiology and Infectious Diseases and Coloproctol...

Eligibility Criteria

Inclusion

  • Patients with ulcerative colitis before therapy and surgery
  • Residents of Tashkent region which does not have any complaints from the gastrointestinal tract (control group)

Exclusion

  • Patients with a diagnosis of Crohn's disease
  • Patients with a toxic megacolon,
  • Patients with a abdominal abscess, -
  • Patients with a symptomatic colonic stricture,
  • Patients with a stoma,
  • Patients with a a history of colectomy,
  • An increased risk of infectious complications (e.g. as a result of recent pyogenic infection, enteric pathogens detected on stool analysis, active or latent tuberculosis, immunodeficiency, hepatitis B or C, or recent live vaccination),
  • Clinically meaningful laboratory abnormalities,
  • Pregnancy or lactation,
  • An unstable or uncontrolled medical disorder,
  • An anticipated requirement for major surgery,
  • Colonic dysplasia or adenomas,
  • Malignant neoplasms.
  • Patients which operated,
  • Ever used immunosuppressants or biological drugs
  • In the presence of pathologic bacteria in gut microbiota, including Clostridium difficile, Salmonella spp, Shigella spp, Campylobacter spp, Yersinia spp, and Mycobacteria.

Key Trial Info

Start Date :

January 1 2015

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2025

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT03441893

Start Date

January 1 2015

End Date

December 31 2025

Last Update

March 3 2023

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.